#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Renal transplant Acute graft versus host disease in liver Thrombotic microangiopathy Thyroid cancer metastatic Endometrial cancer Ewing's sarcoma Autoimmune hepatitis Extra-osseous Ewing's sarcoma metastatic Hypocalcaemia Osteogenesis imperfecta Hairy cell leukaemia Adenocarcinoma pancreas Cortical dysplasia Marginal zone lymphoma refractory Ataxia telangiectasia More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent Rhabdomyosarcoma recurrent – Trials in Disease Sjogren’s syndrome – Basic Information Acquired haemophilia – Treatment Myelodysplastic syndrome with excess blasts Undifferentiated sarcoma – Treatment Advanced systemic mastocytosis Myelodysplastic syndrome with excess blasts – Trials in Disease Mantle cell lymphoma stage II – Treatment Ewing’s sarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ibrexafungerp Azd9550 Acetazolamide Sodium Diazepam GSK5764227 Belumosudil Mesilate Lasmiditan Intestifix Amlodipine Besilate Palmidrol Hepatitis B Surface Antigen Pegcetacoplan Nizaracianine Triflutate Atenolol Other Immunosuppressants Elebsiran Gen1055 Eculizumab Tetracaine Hydrochloride Levocetirizine Dihydrochloride More therapies…

    Learn about Your Condition

    Sickle cell disease Mantle cell lymphoma stage III Naevoid melanoma Hepatic neoplasm Spermatocele Encephalopathy neonatal Liposarcoma recurrent Uveal melanoma Agitation postoperative Cachexia Apathy Gastrectomy Colorectal cancer stage II Malignant melanoma Catatonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopital Henri Mondor – 1 rue Gustave Eiffel

Hopital Henri Mondor – 1 rue Gustave Eiffel

51 Av Du Mal De Lattre De Tassigny, Creteil, 94000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Elranatamab and Lenalidomide with Daratumumab and Lenalidomide for Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Daratumumab
    • Elranatamab
    • Lenalidomide
    France

  • Study on EXL01 for Preventing Crohn’s Disease Recurrence After Surgery in Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Exl01
    France

  • Study on Acoramidis for Preventing Transthyretin Amyloidosis in Young People with a Genetic Risk

    Recruiting

    3 1
    Investigated Diseases:
    • Acquired ATTR amyloidosis
    Investigated Drugs:
    • Acoramidis Hydrochloride
    Belgium Bulgaria Denmark France Germany Greece +6

  • Study on Regorafenib with Cyclophosphamide, Capecitabine, and Aspirin for Patients with Metastatic Colorectal Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • D,L-Lysine Acetylsalicylate
    • Irinotecan Hydrochloride
    France

  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France

  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Myeloproliferative neoplasm
    • Polycythaemia vera
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Apixaban
    • Rivaroxaban
    France

  • Study on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    • Metastases to liver
    • Colorectal cancer
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Capecitabine
    France

  • Study of personalized rituximab dosing using artificial intelligence in patients with membranous nephropathy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glomerulonephritis acute
    Investigated Drugs:
    • Rituximab
    France

  • Study of Pioglitazone and Avelumab Combined with Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients with Complete Cytogenetic Response

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Avelumab
    • Pioglitazone
    France
Previous Page
1 2 3 4 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!